Pharmaceutical Test Data Exclusivity: A Multi-Jurisdictional Survey (AIPPI Law, 7) - Image 1

£80.00

Kluwer Law International Pharmaceutical Test Data Exclusivity: A Multi-Jurisdictional Survey (AIPPI Law, 7)

Name: Pharmaceutical Test Data Exclusivity: A Multi-Jurisdictional Survey (AIPPI Law, 7)
Brand: Kluwer Law International
Price: 80.0 GBP
Availability: InStock

International

It has never been this cheap. We have no record of a lower price.

£80 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 35 days • 35 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 35 days • 1 price levels

Days at Price

Price Analysis

Most common price: £80 (35 days, 100.0%)

Price range: £80 - £80

Price levels: 1 different prices over 35 days

Description

Data exclusivity gives pharmaceutical companies a limited period of time in which clinical test data are exclusive to the innovator. Internationally, however, aside from prohibition against unfair commercial use, there are no specifics as to how these data are protected; exclusivity is available on a jurisdiction-by-jurisdiction basis. This book, the only one of its kind, provides expert guidance, chapter by chapter, on test data exclusivity rights for pharmaceutical products in twenty-two major markets worldwide. For each jurisdiction, in addition to explaining the available regulatory data protection - including both substantive and formal requirements for approvals and testing, protection of undisclosed data, confidentiality, and enforcement in practice - local experts provide detailed information and guidance on the degree to which test data exclusivity may be achieved in such areas of pharmaceutical research as the following: infectious disease products; paediatrics products; chemical and biological products; agricultural products; animal health products; orphan drugs; and new chemical entities. This book originated from a project conducted by the Pharma Committee of the International Association for the Protection of Intellectual Property (AIPPI), the world's leading non-profit association dedicated to the development, expansion, and improvement of international and regional treaties and agreements and national laws relating to intellectual property. Many committee members and observers are authors of chapters in this book. An unmatched starting point for innovator pharmaceutical companies and their advisers to evaluate data exclusivity rules and oppor

Product Specifications

Brand: Kluwer Law International
Format: hardcover
ASIN: 9403501065
Category: Books > Subjects > Business, Finance & Law > Law > International
Domain: Amazon UK
Release Date: 12 August 2022
Listed Since: 24 August 2022

Barcode

No barcode data available

Kluwer Law International Pharmaceutical Test Data Exclusivity: A Multi-Jurisdictional Survey (AIPPI Law, 7)

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Regulatory Protection in the Pharmaceutical and Life Science Industries: Challenges, Opportunities and Ongoing Reform (Elgar Monographs in Intellectual Property Law)

Intellectual Property in the Life Sciences: A Global Guide to Rights and Their Applications, Second Edition

Pharmaceutical Experimental Design (Drugs and the Pharmaceutical Sciences)

Research Handbook on Intellectual Property and the Life Sciences

Intellectual Property and Health Technologies: Balancing Innovation and the Public's Health

Technology Transfer

Development and Evaluation of Drugs: From Laboratory through Licensure to Market

Boosting Pharmaceutical Innovation in the Post-TRIPS Era: Real-Life Lessons for the Developing World

Access to Non-Summary Clinical Trial Data for Research Purposes Under EU Law: 16 (Munich Studies on Innovation and Competition, 16)

Evergreening Patent Exclusivity in Pharmaceutical Products: Supplementary Protection Certificates, Orphan Drugs, Paediatric Extensions and ATMPs

Managing the Drug Discovery Process: Insights and advice for students, educators, and practitioners

Intellectual Property Law and Access to Medicines: TRIPS Agreement, Health, and Pharmaceuticals (Law, Development and Globalization)

Forschung am Menschen: Der Schutz des Menschen - die Freiheit des Forschers (MedR Schriftenreihe Medizinrecht)

Springer - Intellectual Property and Health Technologies

Statistics In the Pharmaceutical Industry: 14 (Chapman & Hall/CRC Biostatistics Series)

Comparative Diagnostic Pharmacology: Clinical and Research Applications in Living-System Models

Regional Cooperation, Intellectual Property Law and Access to Medicines: A Holistic Approach for Least Developed Countries (Routledge Research in Health Law)

Artificial Intelligence for Drug Product Lifecycle Applications

Pharmaceutical Innovation, Competition and Patent Law: A Trilateral Perspective

Drug and Device Product Liability Litigation Strategy

Patent Protection for Second Medical Uses (Aippi Law)

Routledge Intellectual Property and Access to Medicines in Africa

Edward Elgar - Intellectual Property, Pharmaceuticals and Public Health

Dale and Appelbe's Pharmacy and Medicines Law Thirteenth Edition